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The differentiation of macrophages into lipid-filled foam cells is a hallmark of the lung granuloma that 
forms in patients with active tuberculosis (TB). Mycolic acids (MAs), the abundant lipid virulence factors 
in the cell wall of Mycobacterium tuberculosis (Mtb), can induce this foam phenotype possibly as a way 
to perturb host cell lipid homeostasis to support the infection. It is not exactly clear how MAs allow 
differentiation of foam cells during Mtb infection. Here we investigated how chemically synthetic MAs, 
each with a defined stereochemistry similar to natural Mtb-associated mycolates, influence cell foamy 
phenotype and mycobacterial proliferation in murine host macrophages. Using light and laser-scanning-
confocal microscopy, we assessed the influence of MA structure first on the induction of granuloma cell 
types, second on intracellular cholesterol accumulation, and finally on mycobacterial growth. While 
methoxy mycolates (mMA) effected multi-vacuolar giant cell formation, keto-MAs (kMA) induced 
abundant intracellular lipid droplets (LDs) that were packed with esterified cholesterol. Macrophages 
from mice treated with kMA were permissive to mycobacterial growth, whereas cells from mMA 
treatment were not. This suggests a separate yet key involvement of oxygenated MAs in manipulating 
host cell lipid homeostasis to establish the state of TB.  
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Mycobacterium tuberculosis (Mtb), the aetiological agent of tuberculosis (TB), infects approximately 2-3 
billion people globally (1). Though only a minority of infected individuals (<15%) will develop 
pulmonary disease during their lifetime, most remain prolonged asymptomatic carriers that may develop 
active disease later on (1). In this instance bacilli are not entirely cleared, but remain in a state of 
dormancy inside its host. Throughout this period, Mtb resides inside lung granulomas, the main 
histopathology of TB (2). The granuloma milieu is characterised by a multifaceted host immune response 
of containment and destruction, yet Mtb bacilli are able to counteract and evade host defences (3-5). 
During active TB, granulomas are characterised by large cell aggregates of lymphocytes, neutrophils, 
dendritic cells and peripheral fibroblasts (6). Key effector cells of granuloma formation are macrophages, 
which can differentiate into vacuolar multinucleated giant cells (MGCs) or lipid-laden foam cells (7). 
Tuberculous bacilli may reside in foam cells or escape into the cell-free caseous centre of the granuloma 
(2, 7). The biochemical signalling pathways involved in foamy phenotype regulation remain 
understudied. Growing evidence indicates that an advanced metabolic network stands at the centre of the 
unique adaptation of Mtb in its host macrophage (8-10), regulating the manifestation of latent, chronic or 
acute TB. 
 
The Mtb cell envelope comprises intricate layers of peptidoglycan, arabinogalactan, glycolipids, mycolic 
acids (MAs; α-alkyl, β-hydroxy fatty acids) and lipoproteins, with MAs being the dominant constituent 
(11, 12). The structural and biochemical properties of MAs have been reviewed recently (13). In short, 
these wax-like hydrophobic lipids comprise a mycolic motif with long non-functionalised alkyl chain and 
a meromycolate chain with up to two functional groups that can be either oxygenated (distal group) or 
unoxygenated (distal or proximal group) (13). Three main Mtb MA classes exist: the most abundant 
unoxygenated alpha-MA (αMA), the less abundant oxygenated methoxy- (mMA) and the least abundant 
keto-MA (kMA; Fig. 1) (14, 15). Orientation of the proximal cyclopropane differs. αMA essentially 
exists in cis- configuration (though a small amount of trans- may be present), whereas mMA and kMA 












contain either cis- or trans-cyclopropanation with an adjoining methyl branch (11). Whilst the level of 
αMA is fixed at ~53% and oxygenated MA at ~47%, the ratio between the two oxygenated MAs varies 
with methoxy at 32-40% and keto at 7-15% (16), depending on the growth stage of the bacilli (17-19). 
Mtb envelope derived lipids potently influence host immunity (20-22), while host cell lipidomes are 
exploited by intracellular pathogens like Mtb to gain entry and replicate (23). The work by Cole et al. on 
deciphering the Mtb genome identified two distinct sets of complex enzymatic machinery for successive 
biosynthesis of fatty acids, meromycolates and long carbon chain MAs (24). A MA-rich cell wall that can 
be altered depending on physiological requirements is essential for Mtb virulence (17, 18). We previously 
showed that in vivo MA treatment induced peritoneal and alveolar macrophages of the foam phenotype in 
mice (25, 26), similar to that in macrophages from the TB granuloma (27). At the onset of TB infection, 
foam cells form that are characteristically enlarged and filled with multiple lipid droplets (LD) and 
vacuoles (28, 29). Cholesterol is abundantly distributed across cell membranes and forms a major 
constituent of LDs (30, 31). It also plays a unique role in Mtb virulence and pathogenesis. Mtb 
preferentially catabolises cholesterol as nutrient source whilst its acquisition, through a unique Mtb 
import system, is necessary to establish and maintain persistent infection (32, 33). In macrophages, the 
genetic regulator of cellular cholesterol homeostasis is the liver X receptor (LXR) (34). LXRs are 
transcription factors that act as cholesterol sensors and that maintain the balance of cholesterol uptake and 
export through regulation of expression of cholesterol-associated target genes (35).  
 
To better understand the mechanisms responsible for the establishment of active TB related granulomas, 
we investigated how in vivo treatment of mice with chemically synthetic MAs, each with a defined 
stereochemistry representing the separate major classes of Mtb mycolates, influence cell differentiation 
and support of mycobacteria in peritoneal macrophages. We assessed the influence of MA structure first 
on the induction of foamy macrophages and MGCs identified by light and laser-scanning-confocal 
microscopy, second on cholesterol accumulation and finally on intracellular mycobacterial growth. Our 
results show that Mtb mycolates differentially steer host macrophages to either an enlarged vacuolar or a 












lipid-laden foamy phenotype. We report it is kMA that induced mainly cholesterol ester accumulation and 
intracellular LDs to sustain facilitation of mycobacterial BCG proliferation. mMA was found to induce 
vacuolation with no change in cholesterol ester levels, nor improved ability to sustain and facilitate 
mycobacterial growth. αMA treatment had a negligible effect on these parameters. To determine how 
foam cells brought about by non-tuberculous means compares to foam cells induced by the different 
mycolates, we also investigated cholesterol accumulation and mycobacterial growth of peritoneal 
macrophages from LXR-deficient mice. In macrophages with a deficiency in LXR activity that is 
characterised by perturbed cholesterol transport or export, we recorded foam cells with abundant 
cholesterol ester containing LDs that showed elevated BCG replication.  
 
Materials and methods 
Mycolic acids 
Natural MA mixture was isolated and single synthetic MAs synthesised as previously described (16, 36-
38). The single MAs used for in vivo murine treatment in this study all contained cis-cyclopropanation, 
referring to the orientation of the proximal cyclopropane. MA treatments comprised cis-αMA, cis-mMA, 
cis-kMA consisting of a mixture of both epimers of the distal α-methyl-ketone group with S- and R-
stereochemistry, and a natural isolated mixture of all three MA classes (each as a complex mixture of 
homologues) similar to the natural composition of MAs in the Mtb cell wall (MA mix) (Fig. 1), i.e. ~53% 
αMA, ~38% mMA and ~9% kMA.  
 
Animals  
Mice used were specific pathogen-free C57BL/6 WT females, aged eight to twelve weeks (Janvier Labs, 




 mice (39) were bred in the animal facility of Ghent 
University. Animals were housed individually in a temperature- and light- controlled facility and received 
mixed ration feed and water ad libitum. Experiments were preapproved by the Ghent University Ethical 












Committee for Animal Experimentation in accordance with current European laws regarding the welfare 
and humane use of animals. 
 
Experimental design 
Mice were treated intraperitoneally (i.p.) with various control or MA solutions two days prior to 
harvesting of peritoneal exudate cells (PEC). Macrophages from PEC were cultured for three days and 
live cells fluorescently labelled for foam cell markers and examined by laser-scanning-confocal 
microscopy on each day (0 h, 24 h and 48 h time points). The mycobacterial model was similar to the 
foam cell model except that following overnight adherence, cells were infected for 6 h with M. bovis 
bacille Calmette-Guérin expressing the dsRed fluorescent protein (BCG-dsRed; a gift from Prof. Ben 
Appelmelk from the Department of Medical Microbiology and Infection Control at the VU University 
Medical Centre in Amsterdam via the Unit of Medical Biotechnology at the Inflammation Research 
Center in Ghent). After three washes with endotoxin-free PBS (Lonza), the cells were stained with 
fluorescent markers for confocal microscopy (0 h) to assess macrophage morphotype or left for up to five 
days to measure mycobacterial growth (48 h and 96 h). The LXR model was similar to the mycobacterial 
model apart from mice were not treated with MAs prior to harvesting PEC.  
 
Mycobacterial culture and infection 
BCG-dsRed has been described previously (40). The BCG strain Copenhagen (Danish 1331) was used 
here (41), which has no mMA, but similar quantities each of αMA and kMA (42). Bacterial cultures were 
grown in Middlebrook 7H9 broth (Difco) supplemented with 0.2% glycerol, 0.05% Tween-80 and 10% 
Middlebrook AODC enrichment containing oleic acid, albumin, dextrose and catalase (Becton 
Dickinson). BCG expanded to an OD600nm of 0.8-1.0 was used to infect cells ex vivo at a multiplicity of 
infection (MOI) of 1 bacterium per cell for 6 h. Following the 6 h infection, cells were washed three times 
with warm endotoxin-free PBS and cultured at 37°C and 5% CO2. 
 












Injectable solutions and macrophage isolation 
Liposomes were used as carrier to deliver the highly hydrophobic MA compounds to target cells. As a 
first step, L-α-Phosphatidylcholine (PC, Sigma
®
) powder was dissolved in chloroform at 100 mg/ml (10% 
w/v). PC and MA dissolved in chloroform were vortexed and heated before undergoing dehydration on a 
heat block (90°C) and the dried lipids recovered in endotoxin-free PBS. Solutions underwent a series of 
vortex and sonication steps at 65°C until homogenous milky consistency. Mice were immediately treated 
in vivo by i.p. injection (25 µg MA/100 µl/mouse). A liposome control (Lipo) was formulated as 
described for the MA solutions, but without the addition of any synthetic MA. Two days after in vivo 
treatment, mice were euthanized via cervical dislocation and PECs harvested by peritoneal lavage. Mouse 
abdomens were decontaminated with 70% ethanol and 10 ml ice cold endotoxin-free PBS injected i.p. 
Following a short abdominal massage, PECs were removed into sterile 15 ml tubes and kept on ice until 
further processing by centrifugation (1200 rpm, 4°C, 10 min) and red blood cell lysis (ACK lysing buffer, 
Lonza; 50% v/v). PECs were seeded in 250 µl culture medium (5x10
5
 cells) in µ-Slide 8-well microscopy 
plates (Ibidi
®
). Culture medium consisted of RPMI 1640 (Gibco
®
) supplemented with LPS-free and heat-
inactivated FCS (10%), sodium pyruvate (2 mM), non-essential amino acids (1%), 
penicillin/streptomycin antibiotics (0.2%), and β-mercaptoethanol (0.1%). Cultures were enriched for 
macrophages by overnight adherence. All cells were cultured at 37°C and 5% CO2.  
 
Light and laser-scanning-confocal microscopy 




 cells was taken for cytospin analysis. The cytospin 
filter was primed with 100 µl PBS (300 rpm, 1 min) before addition of 200 µl cell suspension (300 rpm, 5 
min). After an overnight drying step, cells were fixed in methanol for 30 min at -20°C and dried for 2 h. 
Cells were stained with undiluted May-Grünwald for 5 min (granular stain), washed in PBS, and stained 
for 20 min in 20x diluted Giemsa (nuclear stain). Cells received a final wash with bi-distilled water and 
were left to dry overnight. At least 200 cells were counted per treatment with a standard light microscope.  
 












Live cells were stained with fluorescent markers for confocal microscopy at the time points specified in 
culture medium without amines and serum at 37°C for 30 min. Nuclear DNA was stained with Hoechst (1 




Blue (10 µM) and neutral LDs with 
Bodipy
®
493/503 (8 µg/ml; Molecular Probes). Cells were washed three times in warm endotoxin-free 
PBS to remove unbound probe and fixed consecutively for 15 min in 2% then 4% paraformaldehyde. 
Macrophages were classified as enlarged vacuole-positive (V+) when their cell size was ≥24 µm and 
multiple large vacuoles were present. Fluorescently labelled cells were viewed on a Leica TCS SP5 
AOBS inverted confocal microscope with a 63x HCX PL Apo 1.4 oil objective and stacked images taken 
at 0.42 µm slices with a spectral photomultipliers DFC320 colour camera (36-bit, 7 megapixels, non-
confocal). Training and technical support was provided by the Bio Imaging Core facility of the Flemish 
Institute of Biotechnology (Ghent).  
 
Quantification of intracellular cholesterol content 
Macrophage intracellular cholesterol was quantified using the Calbiochem
® 
cholesterol/cholesteryl ester 
quantitation kit (Merck Millipore, Cat. No.428901). Cell pellets (1x10
6 
cells) were freeze-thawed five 
times in liquid nitrogen, homogenised with pestle in 200 µl chloroform:isopropanol:NP40 (7:11:0.1, 
v/v/v) and centrifuged for 10 min at 14,000 rpm. The organic lower phase was transferred to a clean 
microcentrifuge tube and air-dried at 50°C. To remove any residual chloroform, samples were further 
vacuum-dried for 30 min at 45°C. The dried lipids were dissolved in 200 µl cholesterol reaction buffer at 
40°C for two cycles of heating (10 min) and vortexing with a final vortex of 5 min. All extracted samples 
and standards were added to a volume of 50 µl in a black 96-well plate followed by 50 µl of reaction mix 
1 (with cholesterol esterase) or 2 (without cholesterol esterase) for determination of total cholesterol and 
free cholesterol, respectively. The assay plate was incubated at 37°C for 60 min; then fluorometrically 
measured on a FLUOstar OMEGA microplate reader (~535/590 nm). Cholesterol standards were plotted 
against relative fluorescence units and the concentration of total, free and esterified cholesterol (free 
subtracted from total) calculated as µg/10
6
 cells. 












Statistical analyses  
The number of mice used for experiments comprised a minimum of five mice per treatment. Data were 
obtained from at least three independent experiments or 500 cells from no less than five separate 
microscopy images. The distribution of all data was determined by a Shapiro-Wilk (W) normality test. 
Nonparametric Mann-Whitney U or Kruskal-Wallis one-way analysis of variance tests (H; with Dunn’s 
ranked sum multiple comparisons) were used to assess the proportion of foam cells in PEC cytospins and 
cellular cholesterol content (dependent variables) for each treatment or cholesterol fraction (categorical 
variables). Generalised linear model analyses (GLM: Poisson distribution with sequential Sidak pairwise 
comparisons) were used to assess counts of the number of cellular vacuoles, LDs, and bacilli (dependent 
variables) for each treatment or MOI at specified time points (predictors). Image processing and 
quantification of cellular markers for confocal microscopy were conducted with Volocity 3D Image 
Analysis Software (PerkinElmer Inc.). All other statistical analyses were performed with IBM SPSS 
Statistics 23 (IBM, Chicago IL, USA) and GraphPad Prism 5 (GraphPad Software, Inc.). Results were 
presented as mean ± standard error of the mean (SEM) and were considered significant at P ≤ 0.05.  
 
Results 
Mycolic acids of the methoxy oxygenation class promote the formation of multi-vacuolar foam cells  
To assess the influence of MA structure on the induction of multi-vacuolar giant foam cells, mice were 
i.p. injected with 25 μg of various MAs (alpha, methoxy or keto) (Fig. 1) or control compounds (PBS or 
liposome carrier without synthetic MA). PECs were harvested two days after treatment. Macrophages 
were examined by cytospin analysis and laser-scanning-confocal microscopy. PEC from mice treated 
with PBS, liposome carrier without synthetic MA (Lipo) and αMA-containing liposomes contained <10% 
vacuolar foam cells (Fig. 2A-B). In contrast, PEC from mice treated with liposomes containing kMA or 
mMA showed ~15% and 27-30% vacuolar foam cells, respectively. GLM analysis showed a clear 
difference among the treatments in their ability to induce vacuoles. mMA clearly effected vacuole 
formation with significantly more enlarged vacuole-positive (V+) cells (25-35%) as compared to kMA (5-












10%) and other treatments (<5%) (Fig. 2C-D). In addition, the proportion of enlarged V+ cells from the 
mMA cell population remained significantly elevated over time when kept in culture. At the 48 h time 
point, the macrophages from mMA treatment remained enlarged, while all other treatments resulted in 
macrophages returning to normal size (<5% enlarged V+ cells) (Fig. 2C). MGCs were seen mainly among 
the enlarged V+ cells induced by mMA (Fig. 2E).  
 
Mycolic acids of the keto oxygenation class induce foam cells rich in cholesterol-laden lipid droplets  
A clear difference was observed among treatments in their ability to induce LD accumulation (Fig. 3). 
kMA significantly induced LDs, up to 3-fold higher in comparison to all other treatments (Fig. 3A). 
Clearly, kMA was the strongest inducer of intracellular lipids in peritoneal mouse macrophages at all time 
points assayed. In order to normalise for LDs involved in regular macrophage metabolic activity, the LD 
number in PBS-treated cells was selected as baseline value against which relative increases or decreases 
of LDs in other treatments were compared. From this relative analysis, kMA again emerged as the MA 
class that significantly and prominently induced an increment in LDs in the macrophages (Fig. 3B-C). To 
further substantiate and quantify the accumulation of LDs in kMA-treated macrophages, the levels of 
intracellular active cholesterol and stored cholesteryl ester was determined in peritoneal macrophages 
isolated two days after oxygenated mMA or kMA treatment. Macrophages from the kMA treatment 
contained substantial intracellular esterified cholesterol, which also accounted for 77% of the total 
cholesterol content (Fig. 3D). Thus, the ratio of esterified-to-free cholesterol was distinctly elevated in the 
LD inducing kMA treatment and not in vacuole inducing mMA treated cells (Fig. 3D-E). 
 
Mycolic acid induced lipid droplet accumulation in macrophages promotes BCG proliferation  
In order to determine to what extent LD induction by kMA or vacuole induction by mMA may affect 
mycobacterial growth, peritoneal macrophages from mice treated with kMA or mMA were infected with 
BCG-dsRed and cultured for five days (Fig. 4A). Control groups again consisted of peritoneal 
macrophages isolated from mice injected with PBS (placebo) or the unoxygenated αMA. Infection of the 












macrophages with BCG did not abrogate the accumulation of LDs in kMA-treated macrophages, nor 
induce as such an accumulation of LDs in placebo- or mMA-treated macrophages (Fig. 4B, upper panel). 
Strikingly, BCG replication was strongly enhanced in the kMA-treated macrophages (Fig. 4C), resulting 
in a near 3-fold increment in BCG numbers compared to the placebo-treated macrophages or 
macrophages treated with mMA (Fig. 4B, lower panel; and 4D). Macrophages from mice treated with a 
natural mixture of MA made up of αMA (~53%), kMA (~9%) and mMA (~38%) showed an intermediate 
induction of LDs as well as BCG replication (Fig. 4B), indicating that the presence of either mMA and/or 
αMA does not inhibit the LD-inducing and BCG proliferative biological function of kMA. 
 
Assessment of mycobacterial growth in LD-accumulating macrophages from LXR-deficient mice 
In order to determine whether foamy macrophages brought about by non-tuberculous means would also 
display elevated intracellular mycobacterial growth similar to kMA-treated macrophages, we investigated 
this parameter in peritoneal macrophages from LXR-deficient KO mice. Macrophages deficient in LXR 
contained abundant LDs sustained over time (Fig. 5A). This was accompanied with intracellular 
accumulation of esterified-to-free cholesterol at a ratio of ~8:1 in KO mice (Fig. 5B). Strikingly, these 
LD-accumulating macrophages, elicited by a deficiency in LXR activity, also showed a significantly 
increased mycobacterial growth as compared to macrophages from WT mice (Fig. 5C).  
 
Discussion 
The hallmark response to Mtb infection is the formation of granulomas that, in spite of being crucial to 
host protection, are exploited by mycobacteria for survival and persistence (43). Granulomas contain 
distinct macrophage populations of which foam cells loaded with neutral lipids and giant cells containing 
abundant vacuoles are characteristic (44). It was shown previously that natural, purified Mtb MA induces 
cellular features similar to those observed in granuloma cell populations (25). However, as MAs are 
heterogeneous, we determined in this study to what extent examples of individual MA classes sustain the 
foamy and/or vacuolar giant cellular traits in macrophages. The clear difference reported here between 












mMA and kMA treatment in murine macrophages – a distinct induction by mMA of vacuoles without 
LDs and an upregulation of LDs without vacuoles by kMA – indicates the occurrence of independent 
triggers for giant versus foamy cell phenotypes during Mtb infection. The pathophysiological significance 
of these independent macrophage responses possibly reflects a strategy by Mtb to persist inside the key 
immune effector cell responsible for its elimination (45-47). In nature, the inflammatory neutral αMA 
class makes up approximately 50% of all MAs whereas the ratio of pro-inflammatory mMA to kMA 
classes in the Mtb bacillus cell wall is variable and may be tuned to complement growth and persistence 
(13, 17, 18). Korf et al. (25) previously showed that macrophages from mice treated with the natural MA 
mixture (similar to the MA mix used in this study) containing approximately 32-40% methoxy mycolates, 
accumulated large intracellular vacuoles like those reported by us here after treatment with pure (100%) 
mMA. Our results furthermore showed that the macrophages harvested from mice after natural MA mix 
treatment, which contains 7-15% keto mycolates, significantly accumulated intracellular LDs and allowed 
for mycobacterial growth, comparable to the macrophages from the pure (100%) kMA treatment group, 
but reduced by about half. One could therefore anticipate that the changes brought about by regulation of 
the MA class composition by Mtb will not be extreme.  
 
LDs are widespread cell organelles dedicated to the storage of neutral lipids like cholesteryl esters (48). 
Numerous studies have reported on the close association of this distinctive lipid organelle with Mtb 
pathogenesis (28, 46, 49-52). The dynamic interaction of the LD with the Mtb-containing vacuole was 
recorded in an in vitro granuloma model by Peyron and team (28). Electron microscopy analyses of foam 
cells showed that phagosomes containing bacilli migrated towards LDs and eventually engulfed them. 
D’Avila et al. (53) observed in a murine model of TB using the vaccine strain BCG, a dose-response in 
LD formation over time. Close associations between LDs and phagosomes were recorded in BCG-
infected treatments, with significant LD induction observed after 24 hours that remained elevated for 
about two weeks after infection. Cytoskeleton arrangement and phosphatidylinositol-3-kinase, an enzyme 
involved in cellular regulation of proliferation, trafficking and metabolism (54), were identified to play 












key roles in the LD recruitment to bacilli-enclosed phagosomes (55). It is thus clear that pathogenic 
mycobacteria regulate biogenesis or accumulation of host cell lipids into LD-confined organelles, which 
may be further manipulated to intimately associate with the phagosomes enclosing the bacilli. An 
important question is the pathophysiological relevance of this association. Research suggests that the LD-
phagosome interaction serves a dual purpose: at one end to benefit the microorganism and at the other to 
aid the host cell in microbe elimination (28, 32, 56). LDs may serve as a nutrient source to the bacillus 
through direct assimilation of host cell lipids (28) or as nutrient reservoir during latency (32). In contrast, 
host cells employ LDs to disseminate important anti-bacterial factors as was recorded in an in vitro study 
of latex bead phagosomes and pathogenic mycobacteria (56). Phagosomes infected with Mtb and exposed 
to distinct lipids (i.e. arachidonate, ceramide and sphingomyelin) induced actin assembly in macrophages, 
a process involved in microtubule organisation and LD trafficking (55). Lipid exposure also effected 
phagolysosomal fusion and decreased phagosome pH, events indicative of phagosome maturation and 
engagement of bactericidal machinery (56). It was noted that the kMA induced LD accumulation in 
macrophages tended to rapidly return to normal after removing the kMA stimulation, while the mMA 
induced vacuolation of the macrophage was maintained after removal of mMA. Enlarged intracellular 
vacuoles, like those induced after treatment with mMA, represent structures formed by invagination of the 
external cell membrane phospholipid bilayer into the cytosol (57). These double-layered vacuoles form 
stable structures that essentially provide a compartment for upholding the bacterium. LDs are 
phospholipid monolayer organelles critically involved in cellular lipid metabolism (58). As dynamic 
structures mediating lipid exchange or consumption, removal of the LD-inducing stimulus can be 
expected to coincide with rapid turnover and/or catabolism of the LDs by cellular machinery.  
 
As indicated above, we confirmed that αMA is functionally neutral and showed that the oxygenated MAs 
effected pronounced changes with remarkable segregation of foam cell features: mMA induced enlarged 
multi-vacuolar cells whereas kMA stimulated cells to accumulate LDs with most of its cholesterol 
converted to the cholesteryl ester storage form. We next verified the relevance of these responses to 












intracellular growth of mycobacteria. Using kMA-induced foamy cells and mMA-induced giant cells, we 
infected these macrophages ex vivo with BCG-dsRed and measured replication of the bacilli over time. 
Our results showed that intracellular growth was promoted in kMA-induced foamy macrophages, but not 
in mMA-induced giant cells. Macrophages classically convert into foam cells through a dysregulation in 
the balance between influx and efflux of cholesterol. Cholesterol is transported to peripheral macrophages 
in LDL that are taken up by the cell through the LDL receptor, or in the oxidized form, through scavenger 
receptors SRA and CD36. Cholesterol efflux is mediated by the transporters ABCA1 and ABCG1 that 
load the cholesterol on HDL for transfer to the liver, a mechanism known as reverse cholesterol transport. 
These processes are regulated by the lipid sensing nuclear receptors LXR and PPARγ. A direct role for 
LXR in mycobacterial foam cell formation has not been reported. However, mice deficient in LXR show 
spontaneous foam cell formation (59). LXR-deficient macrophages may be considered a cell model of the 
late stage of Mtb infection, where the macrophage has been modified to shut off its cholesterol export 
without limiting cholesterol import, aiming at providing a rich sterol nutrition source for mycobacterial 
growth and replication. We therefore investigated whether foam cells generated through a non-infectious 
condition, namely a deficiency in LXR activity, would also facilitate growth and proliferation of BCG 
bacilli. Similar to macrophages from mice treated with kMA, LXR-deficient macrophages accumulated 
cholesteryl ester-rich LDs and were facilitative towards mycobacterial growth. LXR-deficient 
macrophages contained more than double the amount of cholesterol compared to what could be induced 
with kMA and facilitated proliferation to almost double the number of BCG mycobacteria per 100 cells 
after 96 hours. These results suggest that LXR may indirectly function as a negative regulator of 
mycobacterial foam cell formation and mycobacterial growth. Although speculative, this proposition is in 
line with a previous report showing that LXR-activity suppresses the outgrowth of Mtb bacilli in a mouse 
model of pulmonary Mtb infection (60).  
 
Our study addressed the individual contribution that examples of each of the three main classes of MAs 
from Mtb makes towards the induction of foam cells and multi-vacuolar giant cells as well as towards the 












facilitation of intracellular mycobacterial proliferation. All three features are important elements of the 
manifestation of TB in human lungs and were elicited to varying degrees by the individual MA classes 
studied. Thus, we showed here that it is kMA that induces mainly cholesterol ester accumulation within 
intracellular LDs and facilitates mycobacterial BCG proliferation. In contrast, mMA was found to induce 
vacuole formation, characteristic of giant cells found in Mtb lung granulomas, with however no change in 
cholesteryl ester content or an improved ability to sustain and facilitate mycobacterial growth. Finally, 
αMA treatment exerted a negligible effect on all three parameters. These findings suggest separate 
important roles for keto and methoxy oxygenated MA classes in manipulating the host macrophage 
response during the establishment of TB. This new insight may assist in deciphering and targeting the 
Achilles’ heel of the tubercle bacillus according to an approach recently reviewed by Nataraj et al. (61), 
relying on the most recent understanding of how MA is synthesised and differentiated into classes by 
Mtb. Cyclopropanation provides the minimum functionalisation associated with MA virulence (17). 
Dubnau et al. (18) provided evidence that cyclopropanation or functionalisation of the distal group of the 
meromycolic chain represents the first step of a common pathway responsible for generating methoxy and 
keto mycolates. Differential regulation of this single mechanism can thus allow mycobacteria to 
manipulate MA class composition of alpha, methoxy and keto mycolates during growth progression. 
Evidence for this was provided by Yuan et al. (19), who showed that keto mycolates are more abundant 
during the early stage of mycobacterial infection, but gives way to methoxy mycolates that become more 
abundant in the later phase of infection. Our results imply that much may be accomplished by attempting 
to control the switch between methoxy and keto mycolates as a principle of drug treatment to combat TB. 
One argument for this was provided by Slama et al. (62) who showed that mMA was much more 
abundant in the virulent Mtb H37Rv strain than in the attenuated Mtb H37Ra strain. This has to be 
understood in the wider context that other differences between the H37Rv and H37Ra strains were also 
identified, but the researchers then achieved better resolution of the evidence (62): A recombinant Mtb 
H37Rv was generated with a single gene KO of a protein involved in the late stage of MA biosynthesis, 
namely HadC. HadC is a dehydratase that is not catalytically active, but holds the longer form of the 












elongating merochain of MA in a complex with HadB, which catalyses dehydration of a β-hydroxyacyl in 
the merochain to an enoyl. The hadC KO Mtb H37Rv showed a reduction in the abundance of mMA 
similar to that found in Mtb H37Ra (62). It accordingly also had lower virulence, approximating that of 
Mtb H37Ra, lost its cording and biofilming ability and its envelope integrity, thus making it more 
susceptible to the hydrophobic drug rifampicin. It should be noted that these biological effects could not 
only be ascribed to the lowering of the abundance of mMA, because the hadC KO Mtb H37Rv also had a 
larger degree of unsaturation in the merochain and could not produce the small amount of extra-long 
chain MAs of all three classes that are present in the WT Mtb H37Rv.  
 
Whereas the group of Slama (62) demonstrated the advantage of being able to reduce the abundance of 
mMA in Mtb, our results could imply that even more may be achieved by interfering with kMA 
production in Mtb. However, Dubnau et al. (18) managed to create a hma- KO mutant Mtb H37Rv that 
produced no oxygenated MA at all. The mutant Mtb also showed severe loss of virulence, but was still 
able to grow and multiply in a monocytic cell line or in lungs and spleen of infected mice. Thus, kMA 
seems not to be essential for survival of Mtb and is hence not a prime target for the conceptualisation of a 
new anti-TB drug; although we have demonstrated here how kMA allows the mycobacterium to thrive, 
but not survive, in the target host cell. 
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Figure 1. Mycolic acid structures. The biochemical structures of the synthetic MAs are given for examples of 
the alpha (αMA; JR1080), methoxy (mMA; JR1046) and keto (kMA; GK324) classes containing cis-
cyclopropanation. Numbers in brackets represent carbon chain lengths and wiggly line indicates a mixture of 
















































Figure 2. Mycolic acids of the methoxy oxygenation class promote the formation of multi-vacuolar foam 
cells. The proportion of vacuole-rich macrophages was determined by light microscope images of May-
Grünwald-Giemsa stained cells on cytospins and by laser-scanning-confocal microscopy (mean ± SEM). (A) 
Percentage of foam cells in PEC fraction from the control (PBS and Lipo), αMA, mMA and kMA treatments. 
(Shapiro-Wilk: W = 0.801, P < 0.01; Kruskal-Wallis: H = 12.100, P < 0.05, df = 4, n = 3 independent 
experiments). (B) Light microscope images of cytospins showing vacuolar foam cells in PEC fraction. Images 
were taken at 100x oil magnification. Arrows indicate multinucleated giant cells (MGCs). Scale bar: 10 µm. 
(C) Induction of enlarged vacuole-positive (V+) cells is shown for control (PBS and Lipo) and the various 
MA-treated mouse peritoneal macrophages over time, as measured by laser scanning confocal microscopy 
(GLM: Wald Chi-Square = 753.924, P < 0.001, df = 14, n = 5 per time point). (D-E) Laser scanning confocal 
microscopy images showing enlarged V+ cells for PBS, αMA and mMA treatments. Arrows indicate MGCs. 
Stacked images, 63x oil objective. Scale bar: 20 µm. (E) Zoomed images from the mMA treatment in D. 



































































































Figure 3. Mycolic acids of the keto oxygenation class induce foam cells rich in cholesterol-laden lipid 
droplets. The induction of LDs is shown for peritoneal macrophages from control (PBS and Lipo) and αMA, 
mMA and kMA-treated mice (mean ± SEM). (A) LD accumulation in murine macrophages harvested at 
specified time points following the control and various MA treatments (GLM: Wald Chi-Square = 353.662, P 
< 0.001, df =14, n = 5 per time point). (B) Relative induction of LDs over time as compared to PBS (broken 
line). (C) Laser-scanning-confocal microscopy images depicting variation in LD induction for PBS, αMA and 
kMA treatments. Arrows indicate LD filled cells. (D) Cellular cholesterol content of variously treated cells. 
Bars represent total cholesterol, subdivided in the amount of free and esterified cholesterol for each of the 
treatments (µg/10
6
 cells). Upper panel, fraction percentages of free and esterified cholesterol are shown in the 
bars (n = 12 mice; Shapiro-Wilk: W = 0.813, P < 0.05; Kruskal-Wallis: H = 24.726, P < 0.001, df = 3). Lower 
panel, the ratio of esterified-to-free cholesterol is given for the various treatments (Kruskal-Wallis: H = 26.554, 
P < 0.001, df = 3). (E) kMA induced LDs in peritoneal macrophages as identified by the neutral lipid probe 
Bodipy
®























































































































































Figure 4. Mycolic acid induced lipid droplet accumulation in macrophages promotes BCG proliferation. 
Following in vivo treatment with MA, peritoneal macrophages were infected ex vivo with BCG-dsRed (MOI 1, 
broken line) and cultured until timed interval measurements were taken by laser-scanning-confocal microscopy 
(mean ± SEM). (A) Laser-scanning-confocal microscopy images (zoomed) showing macrophages from mock 
or BCG infections. The presence of a BCG-dsRed bacillus can be clearly distinguished. Scale bar: 2.5 µm. (B) 
Upper panel, LD accumulation in peritoneal macrophages over time (GLM: Wald Chi-Square = 636.496, P < 
0.001, df = 17, n = 5 per time point). Lower panel, proliferation of BCG bacilli over time (GLM: Wald Chi-
Square = 250.303, P < 0.001, df = 17, n = 5 per time point). On the X-axis, “Mix” denotes a natural purified 
MA extract consisting of ~53% αMA, ~38% mMA and ~9% kMA. (C-D) Laser-scanning-confocal 
microscopy images depicting a clear difference in the presence of BCG-dsRed bacilli in peritoneal 
macrophages from mice treated with either kMA or mMA. Stacked images, 63x oil objective. Scale bar: 20 


























































































Figure 5. Mycobacterial growth in lipid droplet accumulating macrophages from LXR-deficient mice. 
(A) Macrophages from WT and LXR-deficient mice were cultured for five days and the intracellular LD 
prevalence analysed by laser-scanning-confocal microscopy. KO-cells contained ~10-fold more cellular LDs 
in comparison to WT-cells, though no significant change in the number of LDs per 100 cells was observed 
over time (GLM: Wald Chi-Square = 99.093, P < 0.001, df = 5, n = 4 per time point; sequential Sidak pairwise 
comparisons P > 0.05). Laser-scanning-confocal microscopy images depicting clear morphological differences 
in LD prevalence between WT and KO macrophages. Scale bar: 20 µm.  (B) Cholesteryl esters accounted for 
88% of total cholesterol in LXR-deficient cells (left panel) that also contained significantly elevated ratios of 
intracellular esterified-to-free cholesterol (right panel; Mann-Whitney: U = 144.000, P < 0.001, df = 1, n = 12 
mice). (C) Macrophages from WT and KO mice were infected ex vivo for 6 h with BCG-dsRed (MOI 1, 
broken line) and cultured for five days. Mycobacterial growth was measured by laser-scanning-confocal 
microscopy at specified time points, and was significantly increased in LXR-deficient cells over time (GLM: 
Wald Chi-Square = 576.689, P < 0.001, df = 17; n = 6 per time point; sequential Sidak pairwise comparisons P 
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